• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.

作者信息

Pastores Stephen M, Annane Djillali, Rochwerg Bram

机构信息

Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

General ICU Department, Raymond Poincaré Hospital (APHP), Health ScienceCentre Simone Veil, Université Versailles SQY-Paris Saclay.

出版信息

Crit Care Med. 2018 Jan;46(1):146-148. doi: 10.1097/CCM.0000000000002840.

DOI:10.1097/CCM.0000000000002840
PMID:29095205
Abstract
摘要

相似文献

1
Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.危重症患者危重症相关皮质类固醇激素缺乏症（CIRCI）诊断与管理指南（第二部分）：危重症医学会（SCCM）和欧洲重症监护医学学会（ESICM），2017年
Crit Care Med. 2018 Jan;46(1):146-148. doi: 10.1097/CCM.0000000000002840.
2
Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.危重症患者危重症相关皮质类固醇功能不全（CIRCI）诊断与管理指南（第一部分）：危重症医学会（SCCM）和欧洲重症监护医学学会（ESICM），2017年
Crit Care Med. 2017 Dec;45(12):2078-2088. doi: 10.1097/CCM.0000000000002737.
3
Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.危重症患者危重病相关皮质类固醇功能不全（CIRCI）的诊断与管理指南（第二部分）：危重症医学会（SCCM）和欧洲重症监护医学学会（ESICM），2017年
Intensive Care Med. 2018 Apr;44(4):474-477. doi: 10.1007/s00134-017-4951-5. Epub 2017 Oct 31.
4
[Interpretation of Society of Critical Care Medicine and European Society of Intensive Care Medicine of clinical practice guideline on critical illness related corticosteroid insufficiency in 2017].[《重症医学学会和欧洲重症监护医学学会2017年关于危重症相关皮质类固醇功能不全临床实践指南》解读]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Jun;31(6):669-673. doi: 10.3760/cma.j.issn.2095-4352.2019.06.002.
5
Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.危重病相关皮质激素不足（CIRCI）的诊断和管理指南（第一部分）：危重病医学会（SCCM）和欧洲危重病医学会（ESICM）2017 年。
Intensive Care Med. 2017 Dec;43(12):1751-1763. doi: 10.1007/s00134-017-4919-5. Epub 2017 Sep 21.
6
Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM).危重病相关皮质激素不足（CIRCI）：来自重症监护医学学会（SCCM）和欧洲危重病医学学会（ESICM）多学科工作组的叙述性评论。
Intensive Care Med. 2017 Dec;43(12):1781-1792. doi: 10.1007/s00134-017-4914-x. Epub 2017 Sep 21.
7
Critical Illness-Related Corticosteroid Insufficiency (CIRCI): A Narrative Review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM).危重病相关皮质类固醇功能不全（CIRCI）：来自危重病医学会（SCCM）和欧洲重症监护医学学会（ESICM）多专业特别工作组的叙述性综述。
Crit Care Med. 2017 Dec;45(12):2089-2098. doi: 10.1097/CCM.0000000000002724.
8
Correction to: Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.对《危重症患者危重症相关皮质类固醇功能不全（CIRCI）的诊断与管理指南（第一部分）：危重症医学会（SCCM）和欧洲重症监护医学会（ESICM）2017》的勘误
Intensive Care Med. 2018 Mar;44(3):401-402. doi: 10.1007/s00134-018-5071-6.
9
Critical illness-related corticosteroid insufficiency in children.儿童危重病相关皮质激素不足。
Horm Res Paediatr. 2013;80(5):309-17. doi: 10.1159/000354759. Epub 2013 Nov 7.
10
A call for standardization: Practice patterns and management of critical illness-related corticosteroid insufficiency in surgical intensive care units.呼吁标准化：外科重症监护病房中与危重病相关的皮质类固醇不足的实践模式和管理。
Injury. 2021 Sep;52(9):2522-2525. doi: 10.1016/j.injury.2021.05.036. Epub 2021 Jun 1.

引用本文的文献

1
Critical illness-related corticosteroid insufficiency (CIRCI) - an overview of pathogenesis, clinical presentation and management.危重病相关皮质激素不足（CIRCI）-发病机制、临床表现和治疗概述。
Front Endocrinol (Lausanne). 2024 Nov 6;15:1473151. doi: 10.3389/fendo.2024.1473151. eCollection 2024.
2
Developing a predictive nomogram for mortality in patients with extrapulmonary acute respiratory distress syndrome: the prognostic value of serum soluble thrombomodulin, lung ultrasound score, and lactate.建立肺外急性呼吸窘迫综合征患者死亡率的预测列线图：血清可溶性血栓调节蛋白、肺部超声评分和乳酸的预后价值
Front Pharmacol. 2024 Aug 27;15:1407825. doi: 10.3389/fphar.2024.1407825. eCollection 2024.
3
Comparative Efficacy of High-Dose Dexamethasone Versus Methylprednisolone in Coronavirus Disease 2019 (COVID-19)-Associated Acute Respiratory Distress Syndrome.
高剂量地塞米松与甲泼尼龙治疗2019冠状病毒病（COVID-19）相关急性呼吸窘迫综合征的疗效比较
Cureus. 2024 Mar 7;16(3):e55725. doi: 10.7759/cureus.55725. eCollection 2024 Mar.
4
Adverse Effects Related to Corticosteroid Use in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis.与皮质类固醇用于脓毒症、急性呼吸窘迫综合征及社区获得性肺炎相关的不良反应：一项系统评价和荟萃分析
Crit Care Explor. 2024 Apr 1;6(4):e1071. doi: 10.1097/CCE.0000000000001071. eCollection 2024 Apr.
5
Ventricular Tachycardia Crisis: Assessing Norepinephrine vs. Stress Steroids in the Battle Against Waterhouse-Friderichsen Syndrome With Distributive Shock.室性心动过速危象：在与伴有分布性休克的华-弗综合征的斗争中评估去甲肾上腺素与应激类固醇。
Cureus. 2024 Feb 27;16(2):e55093. doi: 10.7759/cureus.55093. eCollection 2024 Feb.
6
Navigating the Landscape of Hydrocortisone Administration in Septic Shock: Current Concepts and Future Directions.脓毒性休克中氢化可的松给药的现状与展望：当前概念与未来方向
Cureus. 2023 Dec 3;15(12):e49870. doi: 10.7759/cureus.49870. eCollection 2023 Dec.
7
Stress-Dose Steroids: A Potential Therapeutic Option for Refractory Hyperkalemia.应激剂量类固醇：难治性高钾血症的一种潜在治疗选择。
Cureus. 2023 Sep 6;15(9):e44770. doi: 10.7759/cureus.44770. eCollection 2023 Sep.
8
Corticosteroid Therapy in Severe Cases of Pneumonia Caused by SARS-CoV-2.新型冠状病毒肺炎重症病例的糖皮质激素治疗
Cureus. 2022 Dec 29;14(12):e33076. doi: 10.7759/cureus.33076. eCollection 2022 Dec.
9
Could Endogenous Glucocorticoids Influence SARS-CoV-2 Infectivity?内源性糖皮质激素会影响 SARS-CoV-2 感染性吗？
Cells. 2022 Sep 21;11(19):2955. doi: 10.3390/cells11192955.
10
New Insights on Effects of Glucocorticoids in Patients With SARS-CoV-2 Infection.新型冠状病毒感染患者糖皮质激素作用的新认识。
Endocr Pract. 2022 Oct;28(10):1100-1106. doi: 10.1016/j.eprac.2022.07.006. Epub 2022 Jul 21.